Smart Homes Technology Tested in Real Homes - the Giraffplus Project

A safer and healthier old age - that is the aim of GiraffPlus, an international project led by researchers at Örebro University, Sweden. With a focus of developing sophisticated aids for the elderly in close collaboration with the intended users, the project is now about to test the new technology in real homes.

The system has already been tested in a demo apartment in Örebro, but the next step is for researchers in Sweden, Italy and Spain to evaluate the new technology in real homes.

"Two users in Örebro are about to have the system installed. During the autumn, another three homes will be added. In the same way, the technology will be introduced in Malaga and in Rome. All in all, the GiraffPlus system will be tested in 15 different homes in the three countries," says Anette Forsberg, who is overseeing the primary healthcare aspects of the project.

GiraffPlus develops technical solutions that make it possible to continuously monitor, through a network of sensors in the home, an elderly person's health. The sensors can measure blood pressure and body temperature, register movements and detect if someone is lying still for an unusually long period of time, or takes a sudden fall.

The information from the sensors is analysed by an intelligent system, designed to quickly alert the caregiver in emergencies, but it can also be used for long-term assessment of the patient's health.

"The system is designed to be able to, for instance, chart an individual’s sleeping pattern. By measuring the level of activity in the apartment during the night, the system helps both the patient and the caregiver to form a picture of the situation and adequate measures can be introduced," says Professor Silvia Coradeschi at the robotics research centre AASS at Örebro University, who is coordinating the project.

"From a physiotherapist’s perspective, this system provides us with simple and satisfactory ways in which to measure levels of activity and obtain reliable information," says Anette Forsberg.

At the heart of the system is a remote controlled mobile robot, equipped with a display and loudspeaker, known as Giraff. With its help, caregivers can “visit” the patient to discuss and plan care measures based on the information that has been registered by the system.

"During testing, I and a primary healthcare physician will be using Giraff to pay virtual visits to the users based on their needs. In the future, we hope that this model will serve as a good complement to traditional methods as well as provide patients with a choice for their health visits. Some people prefer a visit to the health centre or the hospital, whereas others would rather not make that journey. We are all different," says Anette Forsberg.

Only those that the user has approved will have access to the system and no information will be forwarded without the patient's consent. The goal is to create a user-friendly system, offering services that are perceived as straightforward and of great value, while increasing the users' sense of security and improving their quality of life. Concerned family members

"The user can opt to let others besides the caregiver have access to the information. Perhaps family members who for various reasons are concerned and want to make sure that everything is OK in the apartment or who simply want to pay a virtual visit using Giraff," says Anette Forsberg.

"Long-term evaluation and user interaction are a few of the factors that make our project a unique one. And that input is fundamental if innovative ideas are to bring real benefits to users," says Professor Silvia Coradeschi.

For further information, please visit:
http://www.giraffplus.eu

The GiraffPlus project, which is being coordinated by Örebro University, includes 12 collaboration partners in six European countries. The consortium consists of Consiglio Nazionale Delle Ricerche and Azienda Unita Sanitaria Locale Roma/A ASL RM/A from Italy, University of Malaga and Servicio Andaluz de Salud from Spain, Örebro County Council, Mälardalen University, Lund University and the company Giraff Technologies AB from Sweden and the companies ISA Intellicare (Portugal), Tunstall Healthcare (UK) Limited and XLAB (Slovenia). GiraffPlus is funded by the European Community's Framework Programme Seven (FP7) under contract #288173. FP7 - ICT - Challenge 5: ICT for Health, Ageing Well, Inclusion and Governance.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...